Apolipoprotein B signal peptide polymorphism in relation to lipids and diabetes in male CAD patients

This publication has 8 references indexed in Scilit:

• Relation between the insertion/deletion polymorphism in the gene coding for receptor associated protein (RAP) and plasma apolipoprotein AI (apoAI) and high-density lipoprotein cholesterol (HDL) levels
  Clinical Genetics, 2000
• Single Effects of Apolipoprotein B, (a), and E Polymorphisms and Interaction between Plasminogen Activator Inhibitor-1 and Apolipoprotein(a) Genotypes and the Risk of Coronary Artery Disease in Czech Male Caucasians
  Molecular Genetics and Metabolism, 2000
• Association of the insertion/deletion gene polymorphism of the apolipoprotein B signal peptide with myocardial infarction
  Atherosclerosis, 1998
• Apolipoprotein B (apo B) signal peptide length polymorphisms are associated with apo B, low density lipoprotein cholesterol, and glucose levels in Mexican Americans
  Atherosclerosis, 1996
• Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study.
  Circulation, 1994
• Signal Peptide–Length Variation in Human Apolipoprotein B Gene: Molecular Characteristics and Association with Plasma Glucose Levels
  Diabetes, 1991
• An insertion deletion polymorphism in the signal peptide of the human apolipoprotein B gene
  Human Genetics, 1990
• Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS).
  Journal of Clinical Investigation, 1983